hosphatidylinositol 4,5-bisphosphate (PIP 2 ) is the obligatory precursor of inositol 1,4,5-trisphosphate (InsP 3 or IP 3 ) and is therefore critical to intracellular Ca 2 ϩ signaling. Using RNA interference (RNAi), we identified the short splice variant of type I phosphatidylinositol 4-phosphate 5-kinase ␥ (PIP5KI ␥ 87) as the major contributor of the PIP 2 pool that supports G protein-coupled receptor (GPCR)-mediated IP 3 generation. PIP5KI ␥ 87 RNAi decreases the histamine-induced IP 3 response and P Ca 2 ϩ flux by 70%. Strikingly, RNAi of other PIP5KI isoforms has minimal effect, even though some of these isoforms account for a larger percent of total PIP 2 mass and have previously been implicated in receptor mediated endocytosis or focal adhesion formation. Therefore, PIP5KI ␥ 87's PIP 2 pool that supports GPCR-mediated Ca 2 ϩ signaling is functionally compartmentalized from those generated by the other PIP5KIs.
Introduction
Phosphatidylinositol 4,5-bisphosphate (PIP 2 ) regulates multiple plasma membrane (PM) functions (Doughman et al., 2003; Yin and Janmey, 2003) , and it is also a substrate for PLC-mediated inositol 1,4,5-trisphosphate (InsP 3 or IP 3 ) generation. In spite of PIP 2 's obligatory role as an IP 3 precursor, and the importance of IP 3 mediated Ca 2 ϩ signaling, surprisingly little is known about the identity of the phosphoinositide kinases involved. Unlike yeast, which has a single type I phosphatidylinositol 4-phosphate 5-kinase (PIP5KI) that synthesizes PIP 2 (Audhya and Emr, 2003) , mammals have three major PIP5KI isoforms named ␣ , ␤ and ␥ (Doughman et al., 2003) .
PIP5KI ␥ has two splice variants (PIP5KI ␥ 87 and 90) that are distinguished by a 28-amino acid extension at the COOH terminus of PIP5KI ␥ 90 (Di Paolo et al., 2002; Ling et al., 2002 ; Fig. 1 A) . PIP5KI ␥ 90 is particularly enriched in neurons (Wenk et al., 2001) ; it is the major PIP 2 synthesizing enzyme at the synapse, where it has been implicated in the regulation of clathrin coat recruitment, actin dynamics (Wenk et al., 2001) and focal adhesion formation (Di Paolo et al., 2002; Ling et al., 2002) . In contrast, PIP5KI ␥ 87 is not involved in focal adhesion formation or clathrin-mediated endocytosis (in HeLa cells; Padron et al., 2003) .
Here, we examined the role of PIP5KI ␥ 87 in intracellular Ca 2 ϩ signaling. Previous biochemical studies have shown that cells have agonist-sensitive and -insensitive PIP 2 pools (Koreh and Monaco, 1986) . Inhibitor studies suggest that the agonistsensitive pool can be further classified as constitutive or de novo generated in response to agonists (Nakanishi et al., 1995) . Some of these pools are enriched in cholesterol-sphingolipid raft domains (Pike and Casey, 1996) and the stringent spatial and temporal regulation of Ca 2 ϩ may be specified by assembling key players into supramolecular signaling complexes (Delmas et al., 2004) . We now report that PIP5KI ␥ 87 is the major source of the agonist-sensitive PM PIP 2 pool that fuels the initial Ca 2 ϩ response to external stimuli.
Results and discussion

Knockdown of PIP5KI ␥ 87 by RNA interference
We use small interfering RNA (siRNA) mediated RNA interference (RNAi) to knockdown each PIP5KI individually (Padron et al., 2003) . Anti-PIP5KI ␥ pan antibody recognizes a sharp 87-kD band and a slower migrating diffuse band ( Fig. 1 B) which is probably hyperphosphorylated PIP5KI ␥ 87 (Park et al., 2001; Wenk et al., 2001) . Anti-PIP5KI ␥ pan stains the PM, the perinuclear region and the nucleus (Fig. 1 D) . Low level HA-PIP5KI ␥ 87 overexpression confirms that PIP5KI ␥ is enriched in the PM and punctate internal structures, but rules out nuclear localization. Biochemical fractionation shows that 60% of PIP5KI ␥ 87 is sedimented by high speed centrifugation (Fig. 1 E) , and approximately two thirds of this is associated with the PM enriched fraction. PIP5KI ␣ is much more membrane bound, whereas PIP5KI ␤ is least membrane associated. Therefore, these PIP5KIs have different patterns of membrane association. Nevertheless, each can potentially generate PIP 2 at the PM and internal membranes.
Because it is not possible to knockdown PIP5KI ␥ 87 exclusively, we compared the effects of siRNA directed against both PIP5KI ␥ isoforms (PIP5KI ␥ pan) to that of PIP5KI ␥ 90 alone. PIP5KI ␥ pan siRNA decreases all PIP5KI ␥ bands in Western blots (Fig. 1 B) and reduces PM and cytoplasmic anti-PIP5KI ␥ immunofluorescence, but not the nonspecific nuclear staining (Fig. 1 D) . PIP5KI ␥ 90 siRNA has little effect on either PIP5KI ␥ bands ( Fig. 1 B) , even though quantitative real-time PCR established that PIP5KI ␥ 90 mRNA is decreased by 70% (Fig. 1 C) . We conclude that HeLa cells have very little PIP5KI ␥ 90.
Unexpectedly, PIP5KI ␥ pan siRNA preferentially knocks down PIP5K ␥ 87 mRNA relative to PIP5KI ␥ 90. Because PIP5K ␥ 87 is more abundant than PIP5K ␥ 90 in HeLa cells and PIP5K ␥ pan siRNA generates a distinct phenotype (compared with that of PIP5K ␥ 90 siRNA), the PIP5KI ␥ pan siRNA effects described here can be attributed primarily to PIP5KI ␥ 87 knockdown. Importantly, PIP5KI ␥ pan siRNA has almost no effect on PIP5KI ␣ and ␤ protein expression (Fig. 1 B) , establishing that the PIP5KI ␥ 87 knockdown phenotype is not complicated by compensatory changes in the other PIP5KIs. This was originally a concern, because we have previously found that knockdown of one PIP5KI induces changes in the mRNA level of some other PIP5KIs (Padron et al., 2003) . Histamine binding to the H1 type G protein-coupled receptor (GPCR) in HeLa cells (Tilly et al., 1990) initiates a PLC ␤ activation cascade that culminates in the hydrolysis of PIP 2 to generate IP 3 and diacylglycerol. When control cells were stimulated with a supramaximal histamine dose (100 M), they generate a transient robust IP 3 response (Fig. 2 A) . PIP5KI ␥ 87 RNAi decreases the initial IP 3 peak by 69% [to 10 Ϯ 3 pmol IP 3 /mg protein ( n ϭ 5)] (Fig. 2, A and B) . Neither PIP5KI ␥ 90 nor PIP5KI ␤ RNAi has any apparent effect, and PIP5KI ␣ RNAi only decreases the initial IP 3 peak slightly [by 11%; to 28 Ϯ 2 pmol/mg protein (n ϭ 3)] (Fig. 2 B) . Although we cannot rule out a small contribution by PIP5KI␤ or ␣ because each is less completely knocked down than PIP5KI␥, we can conclude that PIP5KI␥87 is the dominant regulator. Consistent with a decrease in IP 3 production, PIP5KI␥pan RNAi also attenuates histamine-induced Ca 2ϩ sig- Fractions obtained after sequential sedimentation were loaded equivalently, except for the cytosol fraction (CYT), which was loaded 10 times less. Western blot band intensity was determined by quantitative densitometry, and expressed as a percent of total recovered, after correcting for differences in fraction of sample loaded. naling. In control cells, 100 M histamine induces a rapid and transient rise in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) in 95% of the cells examined (Fig. 3 A) . PIP5KI␥87 RNAi reduces the percent of responding cells slightly (by 13%), decreases the amplitude of the first Ca 2ϩ peak more [by 36%; from 1.14 Ϯ 0.07 (n ϭ 19) to 0.73 Ϯ 0.08 (n ϭ 10) fluorescence ratio unit], and has the most impact on Ca 2ϩ flux [76% decrease; from 0.33 Ϯ 0.03 (n ϭ 19) to 0.08 Ϯ 0.01 (n ϭ 10) unit/s] (Fig. 3 A) . Because Ca 2ϩ flux correlates with the open probability of the IP 3 Rs and hence the rate of IP 3 generation (Johenning et al., 2004) , our results establish that PIP5KI␥87 RNAi depletes the PIP 2 pool used for IP 3 generation. A similarly large decrease in Ca 2ϩ flux was also observed when PIP 2 was depleted by overexpressing the PIP 2 phosphatase synaptojanin (Johenning et al., 2004) .
The weakened Ca 2ϩ response by PIP5KI␥87 RNAi cells is not due to depletion of Ca 2ϩ stores, because thapsigargin releases similar amounts of Ca 2ϩ into the cytosol of control and siRNA cells (unpublished data). The [Ca 2ϩ ] i response to UTP, which binds a different GPCR than histamine (P2Y and H1, respectively), is blunted as well (unpublished data). [Ca 2ϩ ] i increase in the presence of 1.3 mM of extracellular Ca 2ϩ (Table S2 , available at http://www.jcb.org/cgi/content/full/jcb.200408008/DC1) is also attenuated, confirming that the lack of PIP 2 impacts the entire Ca 2ϩ signaling cascade that starts with Ca 2ϩ release from internal stores and ends with capacitative Ca 2ϩ entry (that usually follows the depletion of intracellular Ca 2ϩ stores). As expected, in control cells, 1 M histamine induces a slower Ca 2ϩ flux than 100 M histamine [0.24 Ϯ 0.01 (n ϭ 63) vs. 0.33 Ϯ 0.03 (n ϭ 19) fluorescence ratio unit/s]. Paradoxically, PIP5KI␥87 RNAi cells have the same low Ca 2ϩ flux [0.08 Ϯ 0.01 (n ϭ 46) vs. 0.08 Ϯ 0.01 (n ϭ 10) fluorescence ratio unit/s] at both histamine doses. We cannot explain why this is the case. Perhaps because PIP 2 is already limiting at submaximal stimulation, increasing the intensity of the stimulus does not significantly increase the amount of IP 3 generated due to lack of substrate. Unlike PIP5KI␥87 RNAi, PIP5KI␥90, ␣ or ␤ RNAi has much less effects (Fig. 3 A) , paralleling the trend observed with IP 3 production (Fig. 2 B) . Thus, the PIP5KI␥pan siRNA phenotype can be most simply explained by a decrease in the amount of PLC␤ accessible PM PIP 2 and that this pool is generated primarily by PIP5KI␥87.
If PIP5KI␥87 RNAi suppresses Ca 2ϩ signaling by depleting PM PIP 2 , restoring membrane PIP 2 should rescue the Ca 2ϩ response. We used a membrane permeant polyamine shuttle carrier to deliver exogenous PIP 2 into intact cells (Ozaki et al., 2000; Wang et al., 2003) . Control HeLa cells respond to sequential histamine challenges identically, and Shuttle PIP 2 does not change the Ca 2ϩ response significantly (Fig. 3 B) . PIP5KI␥87 RNAi cells, which are already less responsive to the first stimulus than control cells, have an even more blunted response to the second stimulus in the absence of Shuttle PIP 2 (Fig. 3 B, left) . This is consistent with depletion of the already small PIP 2 pool by the first stimulus, and inadequate refilling before the second stimulus. Significantly, Shuttle PIP 2 restores the Ca 2ϩ response of PIP5KI␥87 RNAi cells to ‫%47ف‬ of that observed in Ctrl RNAi cells (Fig. 3 B) . Therefore, the Ca 2ϩ signaling defect is due to PIP 2 depletion by PIP5KI␥ RNAi.
Together, our results demonstrate that PIP5KI␥87 has a critical role in GPCR-mediated IP 3 signaling in HeLa cells. Interestingly, overexpressed mouse PIP5KI␤ (equivalent to human PIP5KI␣ described in this paper) stimulates tyrosine kinase receptor activated-IP 3 generation in B lymphocytes (Saito et al., 2003) . Together, these results raise the intriguing possibility that the GPCR-and tyrosine kinase receptor-coupled PIP 2 pools may be governed by different PIP5KIs. We plan to determine if this is the case in future studies.
Effects of PIP5KI␥87 RNAi on PIP 2 content and distribution
To understand how PIP5KI␥87 uniquely contributes to GPCR mediated IP 3 signaling, we estimated the size and location of its PIP 2 pool relative to those of other PIP5KIs. PIP5KI␥pan siRNA reduces PIP 2 mass, determined by HPLC (Nasuhoglu et al., 2002) , by 14% [from 377 Ϯ 90 (n ϭ 3) to 325 Ϯ 95 (n ϭ 3) pmol/mg protein] and 32 P-incorporation into PIP 2 , determined by TLC, to a similar extent (Fig. 4 A) . PIP5KI␥90 siRNA has no statistically significant effect. PIP5KI␤ RNAi decreases PIP 2 mass by 34% (Fig. 4 A) , which is consistent with the large decrease in [ 32 P]PIP 2 reported previously (Padron et al., 2003 (Padron et al., 2003) , it decreases PIP 2 mass by 33%. The difference between the TLC and HPLC estimates may be because they measure different parameters. 32 P-labeling/TLC detects PIP 2 that turns over during the labeling period, whereas the HPLC method does not involve radiolabeling (Nasuhoglu et al., 2002) and measures PIP 2 mass. It is possible that the 4-h labeling interval we used was not long enough to completely equilibrate a particularly stable PIP 2 pool, and therefore underestimates its size.
PIP5KI␥87 RNAi decreases PM PIP 2 significantly. PIP 2 was detected by single cell fluorescence imaging using overexpressed GFP-PLC␦-PH (Varnai and Balla, 1998; Watt et al., 2002) and anti-PIP 2 (Laux et al., 2000; Matsuda et al., 2001 ; Fig. 4 B) . Although it is generally accepted that the PM is par- ticularly enriched in PIP 2 and that GFP-PLC␦-PH labels the PM intensely, internal GFP-PLC␦-PH labeling has also been reported in at least some types of cells (Matsuda et al., 2001) . However, because GFP-PLC␦-PH was overexpressed and also binds IP 3 (Hirose et al., 1999) , it is difficult to determine if the internal GFP-PLC␦-PH is bound to PIP 2 /IP 3 or represents unliganded PH. This issue is clarified somewhat by a quantitative immuno-electron microscopic study which shows that the PM accounts for 40% of total GST-PLC␦-PH labeling, and internal organelles account for the remainder (Watt et al., 2002) .
Our anti-PIP 2 staining results clearly shows that PIP 2 is present in internal membranes as well as PM in HeLa cells. Using image quantitation (Fig. 4, B and C) , we estimate that anti-PIP 2 fluorescence in the vicinity of the PM accounts for 12.3 Ϯ 1.2% (n ϭ 10) of total, and its intensity is 1.54 Ϯ 0.13 times (n ϭ 10) higher than in internal sites (PM/cytosol ratio; Fig. 4 C). Although these cross-sectional analyses underestimate the size of the PM pool (compared with morphometric analysis by electron microscopy, as described by Watt et al., 2002) , it can be used to compare the effects of different PIP5KI RNAi.
PIP5KI␥pan RNAi decreases the PM anti-PIP 2 intensity from 226 Ϯ 7 to 134 Ϯ 8 arbitrary units (59% of control) and internal PIP 2 from 157 Ϯ 12 to 130 Ϯ 12 arbitrary units (84% of control; Fig. 4 C) . Therefore, PM PIP 2 is preferentially depleted. PIP5KI␤ RNAi decreases anti-PIP 2 intensity at the PM to the same extent (to 58% of control; Fig. 4 B) but has a greater effect on internal PIP 2 (71% of control). In contrast, PIP5KI␣ RNAi has no detectable effect on PM PIP 2 (98% remains after RNAi), but decreases internal staining (76% remaining; Fig. 4, B and C) . The differential responses of PM versus internal PIP 2 is evident when the average intensity of PM PIP 2 is expressed as a ratio to that in the cytosol (Fig. 4 C,  right) . Qualitatively similar, but not identical, changes are also observed with GFP-PLC␦-PH (Fig. 4 C) . Thus, these two independent methods both show that PIP5KI␥87 and PIP5KI␤ RNAi decrease PM PIP 2 , even though only the former suppresses GPCR-mediated IP 3 /Ca 2ϩ signaling. In conclusion, PIP5KI␥87 is the major source of the GPCR mobilized PIP 2 pool. This specialized PIP 2 accounts for a small fraction of total PIP 2 , a significant fraction of PM PIP 2 and most of the histamine induced IP 3 response. The exquisitely selective effect of PIP5KI␥87 RNAi on Ca 2ϩ signaling suggests that the cell's PIP 2 is functionally compartmentalized in a PIP5KI-dependent manner. This study provides a mechanistic understanding of how PIP 2 can regulate multiple PM functions independently. Additional studies will determine if PIP5KI␥87 is part of the supramolecular PLC␤ signaling scaffold that specifies rapid local Ca 2ϩ generation and propagation (Delmas et al., 2004) , and whether the functionally compartmentalized PIP 2 is physically segregated in the PM.
Materials and methods
Antibodies
Anti-PIP5KI␣ was purchased from Santa Cruz Biotechnology, Inc. Anti-PIP5KI␤ and PIP5KI␥pan were gifts from C. Carpenter (Harvard Medical School, Boston, MA) and P. De Camilli (Yale University, New Haven, CT; Wenk et al., 2001) , respectively. Monoclonal anti-PIP 2 (Fukami et al., 1988 ) was a gift from K. Fukami (University of Tokyo, Tokyo, Japan).
RNAi
We used the human PIP5KI isoforms designation, which is different from the mouse designation. siRNA oligonucleotides were performed as described previously (Padron et al., 2003) . HeLa cells were transfected with the siRNA and used 48-72 h later.
Quantitative real-time PCR RNA extracted from HeLa cells transfected with siRNA were reverse transcribed and used for PCR in a sequence detection system (Prism 7000; Applied Biosystems). Primers directed at nucleotides 414-478 (pan) and 1993-2048 (unique to PIP5KI␥90) were used (Padron et al., 2003) .
PIP 2 measurements PIP 2 mass was determined by a nonradioactive HPLC detection system (Nasuhoglu et al., 2002) .
32 P-incorporation into PIP 2 was determined by labeling cells for 4 h with 32 P-PO 4 (NEN Life Science Products), resolving lipids by TLC, and quantitation by phosphorimager analysis . PM PIP 2 was determined by image analysis of cells overexpressing low amounts of GFP-PLC␦-PH (Varnai and Balla, 1998) , or labeling with anti-PIP 2 (Laux et al., 2000; Matsuda et al., 2001) . Fluorescence images were captured by confocal microscopy (model LSM5; Carl Zeiss MicroImaging, Inc.) and intensity plots were analyzed by MetaMorph Offline software (Varnai and Balla, 1998) . The average fluorescence intensity of the two cell edges and between the cell edges were defined as PM and cytoplasmic PIP 2 , respectively, and are expressed in arbitrary units.
Immunofluorescence microscopy
For most purposes, 0.4% formaldehyde fixed cells were permeabilized with Triton X-100 and processed for confocal microscopy as described previously . Anti-PIP 2 staining was detected by permeabilizing fixed cells with 10 g/ml digitonin, which preserves the lipid signal better than Triton X-100.
Multistep membrane fractionation
Cells were homogenized by 25 strokes in a prechilled steel homogenizer and homogenates were centrifuged sequentially to obtain the crude organelle/membrane fractions as described previously (Wei et al., 2002) . LSP is enriched for Golgi membranes and early endosomes, and HSP is enriched for lysosomes and late endosomes. The PM fraction was obtained by placing the 19,000 g pellet on top of a sucrose cushion, and collecting the membranes at the top after centrifugation at 100,000 g.
IP 3 measurement
Cell monolayers incubated in Ca 2ϩ -free Hank's buffer supplemented with 0.1% BSA were stimulated with 100 M histamine (Sigma-Aldrich) for 0-25 s at RT and the reaction was stopped with PCA. IP 3 content was assayed by competition with exogenous [ 3 H]IP 3 to bind calf cerebellar microsomes (Sun et al., 1995) .
Single cell Ca
2ϩ imaging Cells plated on glass-bottom culture dishes (Mat Tek) were loaded with fura2/AM, washed and incubated for 30 min at RT to allow de-esterification of the loaded dye. The dish was mounted on the stage of an inverted fluorescence microscope (Axiovert 200; Carl Zeiss MicroImaging, Inc.) with a 40ϫ objective. Cells were excited at 340 and 380 nm and the change in fluorescence ratio values (F 340 /F 380 ) as a function of time in individual cells within a field was recorded simultaneously. The percent of responding cells was obtained by dividing those with a Ca 2ϩ signal to total cells recorded. The ratio of maximal F 340 /F 380 induced by histamine to basal F 340 /F 380 is defined as the Ca 2ϩ peak. Ca 2ϩ flux is defined as the slope of a line between the initiation of a persistent increase in F 340 /F 380 and the maximal F 340 /F 380 .
Intracellular delivery of PIP 2 by Shuttle PIP 2 siRNA-treated cells were stimulated with 1 M histamine in the absence of extracellular Ca 2ϩ and ratio imaged. Histamine was washed out and cells were loaded with a mixture of 1 M diC16-PIP 2 and 1 M of carrier 2 (Shuttle PIP 2 ; Echelon Biosciences, Inc.) diluted in the Hank's buffer (PIP 2 ) or buffer only (Mock; Wang et al., 2003) for 10-15 min on the microscope stage. Cells were then reexposed to 1 M histamine and imaged again. Table S1 illustrates the effect of PIP5KI RNAi on PIP5KI protein expression. HeLa cells transfected with siRNA for each PIP5KI was lysed and subjected to Western blotting with isoform specific antibodies. 
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